[Auto-aggressive diseases of the skin].
D045930:Anabolic Agents / Q000627:therapeutic use; D000917:Antibody Formation; D000937:Antigen-Antibody Reactions; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001323:Autoantibodies; D001327:Autoimmune Diseases / Q000188:drug therapy / Q000209:etiology / Q000276:immunology; D003877:Dermatitis, Contact; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic; D010392:Pemphigus; D012871:Skin Diseases / Q000188:drug therapy / Q000209:etiology / Q000276:immunology
D045930:Anabolic Agents; D000961:Antilymphocyte Serum; D000970:Antineoplastic Agents; D001323:Autoantibodies; D007166:Immunosuppressive Agents
Autoaggressionskrankheiten der Haut.